Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Ann Biomed Eng. 2016 Aug 24;45(3):632–643. doi: 10.1007/s10439-016-1716-1

Figure 2.

Figure 2

Effect of estrogen on the resistance and compliance of pulmonary vasculature in PAH. (a) The placebo-treated control group (CTL_P), (b) the estrogen-treated control group (CTL_E), (c) the placebo-treated SuHx group (SuHx_P), (d) the estrogen-treated SuHx group (SuHx_E), (e) Resistance (Z0), (f) Characteristic impedance (ZC), (g) Global compliance, and (h) Pulse wave reflection index. * P<;0.05 vs. Control, # P<0.05 vs. Placebo.”